Gujarat Alkalies and Chemicals · NSE: GUJALKALI · BSE: 530001

Q3 FY26 results · Oct–Dec 2025

Gujarat Alkalies and Chemicals reported revenue from operations of ₹1,044.46 crore (up 1.5% from Q3 FY25) and net loss of ₹19.95 crore for Q3 FY26 (Oct–Dec 2025), on a consolidated basis.

Consolidated · ₹ crore
ItemQ3 FY26Q3 FY25YoYQ2 FY26QoQ
Revenue from operations1,044.461,029.41+1.5%1,083.19−3.6%
Other income30.4715.16+101.0%59.29−48.6%
Total income1,074.931,044.57+2.9%1,142.48−5.9%
Profit before share of associates & JVs and tax12.624.45+183.6%13.48−6.4%
Share of profit/(loss) of associates & JVs(8.79)(19.78)0.06
Net profit for the period(19.95)(11.23)Loss widened16.34Turned loss
EPS, basic (₹)(2.72)(1.53)Loss widened2.23Turned loss
Net margin (%)-1.9-1.11.5

This company reports a share of profit/(loss) from associates and joint ventures. BSE’s filing format records that share after tax, so it is shown on its own line. The company’s own statement may add it before its “profit before tax” line.

Standalone · ₹ crore
ItemQ3 FY26Q3 FY25YoYQ2 FY26QoQ
Revenue from operations1,044.461,029.41+1.5%1,083.19−3.6%
Other income30.4715.16+101.0%59.29−48.6%
Total income1,074.931,044.57+2.9%1,142.48−5.9%
Profit before tax12.624.45+183.6%13.48−6.4%
Net profit for the period(11.16)8.55Turned loss16.28Turned loss
EPS, basic (₹)(1.52)1.16Turned loss2.22Turned loss
Net margin (%)-1.10.81.5
Consolidated
Filed with BSE
06 Feb 2026, 18:57 IST
Board meeting
06 Feb 2026
Period
01 Oct 2025 to 31 Dec 2025
Review status
Unaudited
Source
XBRL filing on BSE
Standalone
Filed with BSE
06 Feb 2026, 18:57 IST
Board meeting
06 Feb 2026
Period
01 Oct 2025 to 31 Dec 2025
Review status
Unaudited
Source
XBRL filing on BSE